1-6 of 6
Maurizio Voi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I First-in-Human Study of CUDC-101, a Multitargeted Inhibitor of HDACs, EGFR, and HER2 in Patients with Advanced Solid Tumors

Toshio Shimizu, Patricia M. LoRusso, Kyri P. Papadopoulos, Amita Patnaik, Muralidhar Beeram, Lon S. Smith, Drew W. Rasco, Theresa A. Mays, Glenda Chambers, Anna Ma, Jing Wang, Robert Laliberte, Maurizio Voi, Anthony W. Tolcher
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (19): 5032–5040.
https://doi.org/10.1158/1078-0432.CCR-14-0570
Published: 30 September 2014
View article titled, Phase I First-in-Human Study of CUDC-101, a Multitargeted Inhibitor of HDACs, EGFR, and HER2 in Patients with Advanced Solid Tumors
Open the PDF for Phase I First-in-Human Study of CUDC-101, a Multitargeted Inhibitor of HDACs, EGFR, and HER2 in Patients with Advanced Solid Tumors in another window
Journal Articles

Cancer Network Disruption by a Single Molecule Inhibitor Targeting Both Histone Deacetylase Activity and Phosphatidylinositol 3-Kinase Signaling

Changgeng Qian, Cheng-Jung Lai, Rudi Bao, Da-Gong Wang, Jing Wang, Guang-Xin Xu, Ruzanna Atoyan, Hui Qu, Ling Yin, Maria Samson, Brian Zifcak, Anna Wai See Ma, Steven DellaRocca, Mylissa Borek, Hai-Xiao Zhai, Xiong Cai, Maurizio Voi
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (15): 4104–4113.
https://doi.org/10.1158/1078-0432.CCR-12-0055
Published: 30 July 2012
View article titled, Cancer Network Disruption by a Single Molecule Inhibitor Targeting Both Histone Deacetylase Activity and Phosphatidylinositol 3-Kinase Signaling
Open the PDF for Cancer Network Disruption by a Single Molecule Inhibitor Targeting Both Histone Deacetylase Activity and Phosphatidylinositol 3-Kinase Signaling in another window
Includes: Supplementary data
Journal Articles

Phase I Dose-Escalation and Pharmacokinetic Study of Dasatinib in Patients with Advanced Solid Tumors

George D. Demetri, Patricia Lo Russo, Iain R.J. MacPherson, Ding Wang, Jeffrey A. Morgan, Valerie G. Brunton, Prashni Paliwal, Shruti Agrawal, Maurizio Voi, T.R. Jeffry Evans
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (19): 6232–6240.
https://doi.org/10.1158/1078-0432.CCR-09-0224
Published: 30 September 2009
View article titled, Phase I Dose-Escalation and Pharmacokinetic Study of Dasatinib in Patients with Advanced Solid Tumors
Open the PDF for Phase I Dose-Escalation and Pharmacokinetic Study of Dasatinib in Patients with Advanced Solid Tumors in another window
Includes: Supplementary data
Journal Articles

Phase I Trial with BMS-275183, a Novel Oral Taxane with Promising Antitumor Activity

Linda E. Bröker, Filip Y.F.L. de Vos, Cees J. van Groeningen, Bart C. Kuenen, Helen E. Gall, Michael H. Woo, Maurizio Voi, Jourik A. Gietema, Elisabeth G.E. de Vries, Giuseppe Giaccone
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (6): 1760–1767.
https://doi.org/10.1158/1078-0432.CCR-05-2093
Published: 21 March 2006
View article titled, Phase I Trial with BMS-275183, a Novel Oral Taxane with Promising Antitumor Activity
Open the PDF for Phase I Trial with BMS-275183, a Novel Oral Taxane with Promising Antitumor Activity in another window
Journal Articles

A Phase I Pharmacokinetic and Pharmacodynamic Study of the Farnesyl Transferase Inhibitor BMS-214662 in Combination with Cisplatin in Patients with Advanced Solid Tumors

Helen J. Mackay, Ronald Hoekstra, Ferry A. L. M. Eskens, Walker J. Loos, Donna Crawford, Maurizio Voi, Anne Van Vreckem, T. R. Jeffrey Evans, Jaap Verweij
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (8): 2636–2644.
https://doi.org/10.1158/1078-0432.CCR-03-0327
Published: 20 April 2004
View article titled, A Phase I Pharmacokinetic and Pharmacodynamic Study of the Farnesyl Transferase Inhibitor BMS-214662 in Combination with Cisplatin in Patients with Advanced Solid Tumors
Open the PDF for A Phase I Pharmacokinetic and Pharmacodynamic Study of the Farnesyl Transferase Inhibitor BMS-214662 in Combination with Cisplatin in Patients with Advanced Solid Tumors in another window
Journal Articles

Phase I and Pharmacokinetic Study of the New Taxane Analog BMS-184476 Given Weekly in Patients with Advanced Malignancies

Ruth Plummer, Michele Ghielmini, Paula Calvert, Maurizio Voi, Josette Renard, Gilles Gallant, Elora Gupta, Hilary Calvert, Cristiana Sessa
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (9): 2788–2797.
Published: 01 September 2002
View article titled, Phase I and Pharmacokinetic Study of the New Taxane Analog BMS-184476 Given Weekly in Patients with Advanced Malignancies
Open the PDF for Phase I and Pharmacokinetic Study of the New Taxane Analog BMS-184476 Given Weekly in Patients with Advanced Malignancies in another window